Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979723B details a novel Schiff base purification strategy for Gemcitabine intermediates, ensuring superior purity and yield for pharmaceutical manufacturing.
Advanced synthesis of pazopanib hydrochloride intermediates via safe reductive amination. Cost-effective, scalable routes for API manufacturing supply chains.
Optimized industrial route for MC-1568 HDAC inhibitor. Eliminates chromatography and microwave steps for cost-effective pharmaceutical intermediate manufacturing.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Patent CN102911109A reveals a scalable 4-step route for 6-amino-5-fluoro-1-isoindolinone, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel 5-step synthesis of KRAS G12D inhibitor intermediate 1 from L-proline. Reduces cost and complexity compared to ozonolysis routes.
Patent CN115894503A details a streamlined 5-step synthesis of a key pyrrolizine intermediate from L-proline, offering significant cost reduction and safer processing for API manufacturing.
Patent CN112552184B reveals a scalable 4-step synthesis for cyclopropyl chiral amines, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Patent CN114853838B reveals a low-cost, high-yield preparation method for abiraterone acetate, offering significant supply chain advantages for pharmaceutical manufacturers.
Patent CN111440151A details a streamlined 3-step synthesis of Pralsetinib using Rieke Zinc coupling, offering high purity >99.6% and reduced manufacturing costs.
Patent CN103848849A details a high-yield Everolimus preparation technology. This report analyzes the cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel preparation method improves purity and yield. Green chemistry approach reduces toxicity. Reliable supply chain partner for oncology APIs.
Patent CN111440147B details a convergent route for Imatinib intermediates with high purity and mild conditions, offering reliable supply chain solutions.
Patent CN103319311A details a high-efficiency iridium-catalyzed route for (1S)-1-(2,6-dichloro-3-fluorophenyl)ethanol, offering superior ee values and scalability for API production.
Discover a novel industrial route for Apalutamide intermediates using copper catalysis. This patent-backed method ensures high purity, safety, and cost-effective manufacturing.
Patent CN115385920A details a scalable BTK inhibitor refining method achieving 99.4% purity without column chromatography, offering significant cost reduction in API manufacturing.
Advanced patent CN107954919B reveals a green Fischer indole route for Rucaparib intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN108059599B reveals a cost-effective route for Venetoclax intermediates. Discover how this novel one-pot method reduces production costs and ensures high purity.
Novel 3-step route for kinase inhibitor intermediates eliminates high-pressure CO. Enhances safety and scalability for reliable pharmaceutical supply chains.